RHYTHM PHARMACEUTICALS, INC. (RYTM) Current Income Tax Expense (Benefit) USD 2016 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
Summary
Rhythm Pharmaceuticals, Inc. annual Current Income Tax Expense (Benefit) history and growth rate from 2016 to 2023.
  • Rhythm Pharmaceuticals, Inc. annual Current Income Tax Expense (Benefit) for 2023 was $564 K.
  • Rhythm Pharmaceuticals, Inc. annual Current Income Tax Expense (Benefit) for 2018 was $0.000.
  • Rhythm Pharmaceuticals, Inc. annual Current Income Tax Expense (Benefit) for 2017 was $0.000.
Current Income Tax Expense (Benefit), Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $564 K Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2018 $0 $0 Jan 1, 2018 Dec 31, 2018 10-Q 2019-11-01
2017 $0 $0 Jan 1, 2017 Dec 31, 2017 10-Q 2018-11-09
2016 $0 Jan 1, 2016 Dec 31, 2016 10-Q 2017-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.